153 related articles for article (PubMed ID: 2558549)
1. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase.
Willis RC; Nord LD; Fujitaki JM; Breen TS; Matsumoto SS
Adv Exp Med Biol; 1989; 253B():7-12. PubMed ID: 2558549
[No Abstract] [Full Text] [Related]
2. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency.
Becker MA; Kim M; Husain K
Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968
[No Abstract] [Full Text] [Related]
3. Methylmercaptopurine ribonucleoside toxicity in human fibroblasts: inhibition of phosphoribosylpyrophosphate synthetase as well as amidophosphoribosyltransferase.
Yen RC; Becker MA
Adv Exp Med Biol; 1979; 122B():137-43. PubMed ID: 232627
[No Abstract] [Full Text] [Related]
4. Inhibition of phosphoribosylpyrophosphate synthesis in human fibroblasts by 6-methylthioinosinate.
Yen RC; Raivio KO; Becker MA
J Biol Chem; 1981 Feb; 256(4):1839-45. PubMed ID: 6257688
[No Abstract] [Full Text] [Related]
5. Inhibition of phosphoribosylpyrophosphate synthetase by 4-methoxy-(MRPP) and 4-amino-8-(D-ribofuranosylamino) pyrimido[5,4-d]pyrimidine (ARPP).
Nord LD; Willis RC; Breen TS; Avery TL; Finch RA; Sanghvi YS; Revankar GR; Robins RK
Biochem Pharmacol; 1989 Oct; 38(20):3543-9. PubMed ID: 2479382
[TBL] [Abstract][Full Text] [Related]
6. Regulation of purine nucleotide synthesis in human B lymphoblasts with both hypoxanthine-guanine phosphoribosyltransferase deficiency and phosphoribosylpyrophosphate synthetase superactivity.
Becker MA; Kim M; Husain K; Kang T
J Biol Chem; 1992 Mar; 267(7):4317-21. PubMed ID: 1311306
[TBL] [Abstract][Full Text] [Related]
7. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
Lachant NA; Zerez CR; Tanaka KR
Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
[TBL] [Abstract][Full Text] [Related]
8. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
Zoref E; De Vries A; Sperling O
J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
[TBL] [Abstract][Full Text] [Related]
9. Regulation of phosphoribosylpyrophosphate synthetase by endogenous purine and pyrimidine compounds and synthetic analogs in normal and leukemic white blood cells.
Danks MK; Scholar EM
Biochem Pharmacol; 1982 May; 31(9):1687-91. PubMed ID: 6285931
[TBL] [Abstract][Full Text] [Related]
10. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
[No Abstract] [Full Text] [Related]
11. Potent and specific inhibitors of mammalian phosphoribosylpyrophosphate (PRPP) synthetase.
Willis RC; Nord LD; Fujitaki JM; Robins RK
Adv Enzyme Regul; 1989; 28():167-82. PubMed ID: 2560324
[TBL] [Abstract][Full Text] [Related]
12. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
[No Abstract] [Full Text] [Related]
13. Biochemical pharmacology and antitumor properties of 4-amino-8-[beta-D-ribofuranosylamino]pyrimido-[5,4-d]pyrimidine.
Jackson RC; Boritzki TJ; Cook PD; Hook KE; Leopold WR; Fry DW
Adv Enzyme Regul; 1989; 28():185-99. PubMed ID: 2560325
[TBL] [Abstract][Full Text] [Related]
14. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
Becker MA; Losman MJ; Simmonds HA
Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
[No Abstract] [Full Text] [Related]
15. Consequences of inhibition of purine biosynthesis de novo by 6-methylmercaptopurine ribonucleoside in cultured lymphoma L5178Y cells.
Woods RA; Henderson RM; Henderson JF
Eur J Cancer (1965); 1978 Jul; 14(7):765-70. PubMed ID: 658102
[No Abstract] [Full Text] [Related]
16. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
17. [PRPP synthetase superactivity].
Fujimori S
Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
[TBL] [Abstract][Full Text] [Related]
18. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
[TBL] [Abstract][Full Text] [Related]
19. NAD synthesis by erythrocytes in phosphoribosylpyrophosphate synthetase (PRPPs) superactivity.
Micheli V; Simmonds HA
Adv Exp Med Biol; 1989; 253A():1-7. PubMed ID: 2560329
[No Abstract] [Full Text] [Related]
20. Characterization of purine nucleotide metabolism in cultured fibroblasts with deficiency of hypoxanthine-guanine phosphoribosyltransferase and with superactivity of phosphoribosylpyrophosphate synthetase.
Zoref-Shani E; Sperling O
Enzyme; 1980; 25(6):413-8. PubMed ID: 6258915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
